Septerna, Inc. 8-K

What Happened
Septerna, Inc. announced in a Form 8-K (filed January 12, 2026) that it will conduct meetings with participants attending the 44th Annual J.P. Morgan Healthcare Conference during the week of January 12, 2026. The company furnished its corporate presentation as Exhibit 99.1 to the filing as part of a Regulation FD disclosure.

Key Details

• Filing date: January 12, 2026 (Form 8-K, Item 7.01 — Regulation FD Disclosure).
• Event: 44th Annual J.P. Morgan Healthcare Conference, week of January 12, 2026.
• Material furnished: Corporate Presentation of Septerna, Inc., dated January 2026 (Exhibit 99.1).
• Administrative exhibits: Exhibit 99.1 furnished and Exhibit 104 (Cover Page Interactive Data File) included.

Why It Matters
The J.P. Morgan Healthcare Conference is a major investor and industry event where biopharma companies provide program and strategy updates. By furnishing the presentation under Regulation FD, Septerna is making its investor-facing materials public and ensuring equal access to the information. Investors should review Exhibit 99.1 for updates on pipeline, strategy, or corporate priorities presented at the conference and watch for any follow-up disclosures or earnings updates.